cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports Inhibitors of NAD+ Production in
Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives PMC Nicotinamide N Methyltransferase (NNMT) and Liver Cancer: From Metabolic Networks to Therapeutic Targets Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers Nicotinamide N Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




